A report of two cases of disseminated cutaneous leishmaniasis in Santander, Colombia;Leishmaniasis cutánea diseminada: Reporte de dos casos en Santander, Colombia

Revista de Salud Publica

Volumn 11, Issue 1, 2009, Pages 145-150

  Rincón, Melvin Y ^a   Silva, Sandra Y ^a   Dueñas, Ruby E ^a   López Jaramillo, Patricio ^a,b  

^a FUNDACIÓN CARDIOVASCULAR DE COLOMBIA   (Colombia)

^b UNIVERSIDAD DE SANTANDER   (Colombia)

Author keywords

Colombia. (source: MeSH; Diffuse cutaneous leishmaniasis; Leishmania; NLM)

Indexed keywords

EID: 70349586969     PISSN: 01240064     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0124-00642009000100015     Document Type: Article

References (18)

1. Davies C, Kaye P, Croft SL, Sundar S. Leishmaniasis: new approaches to disease control. BMJ 2003;326: 377-82.
2. King RJ, Campbell-Lendrum D, Davies C. Predicting Geographic Variation in Cutaneous Leishmaniasis, Colombia. Emerging Infectious diseases. 2004; 10: 598-607.
3. Ejercito de Colombia, [Internet]. Disponible en: http://www.ejercito.mil.co/index.php?idcategoria=75292. Consultado: Octubre 2008.
4. Picsopo TV, Mallia Azzopardi C. Leishmaniasis. Postgrad Med J. 2006 Oct; 82 (972): 649 - 57.
5. Castellucci L, Cheng L, Araújo C, Guimarães LH, Lessa H, Machado P et al. Familial Aggregation of Mucosal Leishmaniasis in Northeast Brazil. Am. J. Trop. Med. Hyg 2005;73: 69-73.
6. Pirmez C, Yamamura M, Uyemura M, Paes-Oliveira M, Conceicao-Silva F, Modlin RL. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 1993;91:1390-95.
7. Silveira F, Lainson R, Corbett C. Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review. Mem.Inst.Oswaldo Cruz 2004; 99 (3):239-251.
8. Silveira F, Lainson R, Corbett C. Further observations on clinical, histopathological, and immunological features of borderline disseminated cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis. Mem.Inst.Oswaldo Cruz 2005; 100 (5):525-34.
9. Murray H, Berman J, Davies C, Saravia N. Advances in leishmaniasis. Lancet 2005; 366 (9496):1561- 1577.
10. Osorio LE, Castillo CM, Ochoa MT. Mucosal Leishmaniasis due to Leishmania (viannia) Panamensis in Colombia: clinical characteristics Am. J. Trop. Med. Hyg 1998;59: 49-52.
11. Silva-Vergara ML, Silva L de A, Maneira FR, da Silva AG, Prata A. Azithromycin in the treatment of mucosal leishmaniasis. Med Trop Sao Paulo 2004; 46: 175-77.
12. Sight S. New developments in diagnosis of leishmaniasis. Indian J Med Res 2006; 123: 311-330.
13. Adazeh B, Samad A, Ardehali S. Histological spectrum of cutaneous leishmaniasis due to Leishmania tropica. Transactions of the Royal Society of Tropical Medicine and Hygiene 1985; 79: 631-63.
14. Calvopina M, Gomez E, Uezato H, Kato H, Nonaka S, Hashiguchi Y. Atypical clinical variants in New World cutaneous leishmaniasis: disseminated, erysipeloid, and recidiva cutis due to Leishmania (V.) panamensis. Am.J.Trop.Med Hyg. 2005; 73 (2):281-284.
15. Mansueto P, Vitale G, Di Lorenzo G, Rini GB, Mansueto S, Cillari E. Immunipathology of leishmaniasis: an update. Int J Immunopathol Pharmacol. 2007; 20(3):435-45.
16. Rosenthal E, Marty P, del Giudice P, Pradier C, Ceppi C, Gastaut JA, et al. HIV and Leishmania coinfection: a review of 91 cases with focus on atypical locations of Leishmania. Clin Infect Dis 2000; 31: 1093-1095.
17. Couppie P, Clyti E, Sobesky M, Bissuel F, Del Giudice P, Sainte-Marie D, et al. Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana. Br J Dermatol 2004; 151: 1165-1171.
18. Silva SY, Rueda LC, Lopez M, Velez ID, Rueda-Clausen CF, Smith DJ et al. Double blind, randomized controlled trial, to evaluate the effectiveness of a controlled nitric oxide releasing patch versus meglumine antimoniate in the treatment of cutaneous leishmaniasis [NCT00317629]. Trials 2006; 7:14.